Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAIREA Regulatory News (AIEA)

Share Price Information for AIREA (AIEA)

Share Price is delayed by 15 minutes
Get Live Data
27.50    0.00 (0.00%)
Bid:
27.00
Ask:
28.00
Spread: 1.00 (3.704%)
Market Cap: £10.94m
AIEA Live PriceLast checked at - London Stock Exchange

Intraday AIREA Share Chart

Final Results

29 Sep 2008 07:00

RNS Number : 4867E
Airea PLC
29 September 2008
Β 

ο»Ώ

AIREAΒ plc

Preliminary results for the year endedΒ 30thΒ June 2008

Review of operations

Introduction

Over the last twelve monthsΒ we haveΒ completed a number ofΒ previously advisedΒ projects. TheseΒ includeΒ the sale of the specialist yarns division, theΒ disposalΒ ofΒ certain freeholdΒ properties, re-engineering the residential carpetsΒ businessΒ andΒ streamliningΒ theΒ management team.

Financial statements

TheΒ consolidatedΒ financial statementsΒ are presented under International Financial Reporting Standards for the first time. There are a number of presentational changes, the most significant of which is the analysis of the results between continuing operations and discontinued operations on the face of the consolidated income statement.

The only significant changesΒ to theΒ consolidatedΒ resultsΒ reported previouslyΒ areΒ changes to the deferred tax position at 30th June 2007 and the factΒ that goodwill is no longer amortised,Β withΒ amounts previously amortised since 1st July 2006 beingΒ reinstated in the consolidated balance sheet. ProvisionsΒ for impairment of the goodwill associated with theΒ residential floor coverings business and theΒ subsidiary yarn dyeing business haveΒ then been included in the income statement for the current period.

Continuing operations

Continuing operations consist of the Burmatex commercial floor coverings business and the Ryalux residential floor coverings business. Sales reduced by 1% to Β£48.7m (2007: Β£49.3m) with growth in commercial products being offset by a decline in residential products. Burmatex has continued to benefit from the changes to the product range and the greater focus on marketing activities implemented in recent years. The decline in sales of residential products was partly due to range rationalisation and partly due to the difficult market conditions. Whilst the board remains fully committed to the residential floor coverings business, in the light of the results from the business and the challenging market conditions,Β it hasΒ madeΒ a significantΒ provision for the goodwill associated with this business.

The operatingΒ profitΒ was Β£1.9m (2007: Β£0.8m) but the year to 30th June 2008 includes an exceptional profit on sale of property of Β£9.9m (2007: Β£nil)Β and a provision for impairment of goodwill of Β£8.0m (2007: nil). After excluding this exceptional profit, the provision for impairment of goodwillΒ and other exceptional costs of Β£0.4m (2007: Β£0.7m), operating profit before exceptional items was Β£0.5m (2007: Β£1.5m).

EarningsΒ per share from continuing operationsΒ wereΒ 0.94p (2007:Β 5.65p) and adjusted earnings per share, excluding the effect of the exceptional profit on sale of property, theΒ related deferred taxΒ movements, the provision for impairment of goodwillΒ and the other exceptional costs, wasΒ 1.94pΒ (2007: 1.03p).

Discontinued operations

Discontinued operations consist of the specialist yarns businessΒ whichΒ was sold on 2nd November 2007Β and the yarn dyeing business which was closed in May 2008. Sales to the date of disposalΒ or closureΒ were Β£6.3m (2007: Β£16.1m). The operating loss was Β£3.8m (2007: profit Β£0.8m) but this includes a loss on disposal of Β£2.7m (2007: Β£nil), a provision for impairment of goodwill,Β consequentΒ upon the closure of the yarn dyeing business,Β of Β£0.8m (2007: nil) andΒ other exceptional costs of Β£0.5m (2007: Β£45,000). After excluding theseΒ items, operating profit was Β£0.2m (2007: Β£0.9m).

Discontinued operations generated a loss per share ofΒ 8.75p (2007: earnings per share 1.05p). AdjustedΒ lossΒ per share, excluding the effect of the loss on disposal,Β the provision for impairment of goodwill and the other exceptional costs,Β wasΒ 0.42p (2007:Β adjustedΒ earnings per shareΒ 1.12p).

Group results

Total turnover for the year was Β£55.0m (2007: Β£65.3m). This represents a reduction of 16% due to the disposal of the specialist yarns business part way through the year combined with a decline in the sales of residential carpets. The resultΒ for the year, after accounting for the operatingΒ resultsΒ described above, finance income totalling Β£0.6m (2007: Β£nil), finance costs of Β£0.2m (2007: 0.8m) and a taxΒ chargeΒ of Β£2.1m (2007: taxΒ creditΒ Β£2.3m), wasΒ a loss ofΒ Β£3.6m (2007:Β profit ofΒ Β£3.1m).

There was a net cashΒ outflow fromΒ operating activitiesΒ ofΒ Β£4.1m (2007:Β inflow ofΒ Β£4.5m). The main reasons for the change from last year wereΒ an increaseΒ in working capital, compared to a reduction the previous year, and increased contributions to the defined benefit pension scheme. After accounting for the sale of properties and the specialist yarns business there was a net increase in cash and cash equivalents of Β£7.5m from Β£1.5m negative to Β£6.1m positive and an elimination ofΒ Β£3.7m ofΒ debt. A further substantial reduction in the pension deficit was achieved in the year and this now stands at a gross figure of Β£5.5m (2007: Β£8.4m).

The loss per share wasΒ 7.81p (2007: earnings per share 6.70p) and adjusted earnings per share, excluding the effect of the exceptional profit on sale of property, the related deferred tax movements, the provisions for impairment of goodwill, the loss on sale of the specialist yarns business and other exceptional costs were 1.52p (2007: 2.15p).

An interim dividend of 0.80p per share was paid in May 2008. In view of the results for the year, the board have given carefulΒ considerationΒ to the level of final dividend but having taken into account the cash generated from disposals during the year, the board consider it appropriate to propose a maintained final dividend of 1.60p per share. This gives an unchanged total dividend of 2.40p per share for the year. If approved, this dividend will be paid on 25th November 2008 to shareholders on the register at the close of business on 24th October 2008. The board will keep the dividend policy under review and future dividends will be based upon future levels of profitability and cash flow.

Key performance indicators

As part of its internal financial control procedures the board monitors certain financial ratios. For the year to 30th June 2008 sales per employee amounted to Β£122,000 (2007: Β£107,000), operating return on sales was 1.3% (2007: 3.6%), return on average net operating assets was 2.2% (2007: 5.7%) and working capital to sales percentage was 16.1% (2007: 18.2%). Sales per employee improved due to the rationalisation of staffing within the residential floor coverings business.Β Β The operating return on sales and the return on average net operating assets reduced as a consequence of the challenging market conditions. The working capital ratio improved following the disposal of the specialist yarns business.

Management and personnel

Steve Harrison, the former chief operating officer, left the group on 29th February 2008. Neil Rylance joined the group as managing director of the floor coverings business on 2nd June 2008 and was appointed chief executive officer on 13th June 2008. We would likeΒ toΒ thank all our team members throughout the group for their ongoing commitment and support during a challenging period.

Current trading and future prospects

We continue to operate inΒ highly competitiveΒ marketΒ conditions. In view of this,Β and the economic downturn in the UK,Β the start to the new financial year has been mixed with sales ahead of last year at Burmatex but down on last year at Ryalux. Overall sales in continuing activities are currently runningΒ approximately 5%Β belowΒ last year and margins remain under pressure.

Despite theseΒ challenges,Β weΒ continue to focus on streamlining the business,Β not onlyΒ toΒ reduce cost butΒ alsoΒ to increase effectiveness, flexibility and speed of response with a view to improving profitability and securing the futureΒ of the group.

Work on the residential business isΒ a major priorityΒ and the current year will see further rationalisation of the product range, furtherΒ streamlining ofΒ the manufacturing operationsΒ and aΒ renewedΒ focus on new product development. As we moveΒ forwards, weΒ expectΒ the BurmatexΒ operationΒ toΒ continue to improve and the RyaluxΒ businessΒ toΒ start to move back into an acceptable trading position.

Enquiries:

Neil RylanceΒ  01924Β 266561

Chief executiveΒ officer

Kevin Henry 01924Β 266561

Group finance director

Andrew KitchingmanΒ  0845 270 8610

Managing Director - Corporate Finance

Brewin Dolphin

The financial information set out in this preliminary announcement does not constitute statutory accounts as defined in section 240 of the Companies Act 1985.Β 

The consolidated balance sheet at 30thΒ June 2008 and the consolidated income statement,Β theΒ statement ofΒ recognised income and expense and theΒ consolidated cash flow statement for the year then ended have been extracted from the Group's 2008Β statutory financial statements upon which the auditor's opinion is unqualified and does not include any statement under section 237 of the Companies Act 1985.Β 

The announcement has been agreed with the company's auditor for release.

Consolidated Income Statement

year ended 30th June 2008

2008

Β 2007Β 

Β£000

Β£000

CONTINUING OPERATIONS

Revenue

48,713Β 

49,270Β 

Operating costs

(48,648)

(48,461)

Impairment of goodwill

(8,012)

-

Exceptional profit on sale of property

9,858Β 

-

Operating profit after exceptional items

1,911

809Β 

Analysed between:

Operating profit before exceptional items

Β 

484Β 

Β 

1,511Β 

Exceptional operating costs

(419)

(702)

Impairment of goodwill

(8,012)

-

Exceptional profit on sale of property

Β 

9,858Β 

Β 

-

Finance income

383Β 

-

Finance costs

(237)

(671)

Profit before taxation

2,057

138Β 

Taxation

(1,623)

2,475Β 

Profit from continuing operations

434

2,613Β 

DISCONTINUED OPERATIONS

Revenue

6,329Β 

16,060Β 

Operating costs

(6,570)

(15,243)

Impairment of goodwill

(845)

-

Loss on disposal of discontinued operations

(2,668)

-

Operating (loss)/profit after exceptional items

(3,754)

817Β 

Analysed between:

Β 

Β 

Β 

Β 

Operating profit before exceptional items

245Β 

862Β 

Exceptional operating costs

(486)

(45)

Impairment of goodwill

(845)

-

Loss on disposal of discontinued operations

Β 

(2,668)

Β 

-

Finance income

188Β 

-

Finance costs

-

(166)

(Loss)/profit before taxation

(3,566)

651Β 

Taxation

(481)

(168)

(Loss)/profit from discontinued operations

(4,047)

483Β 

(Loss)/profit for the year

(3,613)

3,096Β 

(Loss)/earnings per share

Β (basic and diluted)

(7.81)p

6.70p

Earnings per share from continuing operations

Β (basic and diluted)

0.94p

5.65p

(Loss)/earnings per share from discontinued operations

Β (basic and diluted)

(8.75)p

1.05p

Consolidated Balance Sheet

as at 30th June 2008

2008

2007

Β£000

Β£000

Β£000

Β£000

Non-current assets

Property, plant and equipment

8,865Β 

10,086Β 

Goodwill

4,000

12,857Β 

Deferred tax asset

1,540Β 

2,520Β 

Loan notes

300Β 

-

14,705Β 

25,463Β 

Current assets

Inventories

10,970Β 

13,312Β 

Trade and other receivables

8,793Β 

10,442Β 

Income tax receivable

448Β 

240Β 

Deferred tax asset

-

1,260Β 

Cash and cash equivalents

6,063Β 

176Β 

26,274Β 

25,430Β 

Non-current assets classified as held for sale

452Β 

5,643Β 

Total assets

41,431Β 

56,536Β 

Current liabilities

Trade and other payables

(10,891)

(11,849)

Borrowings

-

(5,394)

(10,891)

(17,243)

Non-current liabilities

Pension deficit

(5,500)

(8,400)

Deferred tax

(252)

(738)

(5,752)

(9,138)

Total liabilities

(16,643)

(26,381)

24,788Β 

30,155Β 

Equity

Called up share capital

11,561Β 

11,561Β 

Share premium account

504Β 

504Β 

Capital redemption reserve

2,395Β 

2,395Β 

Retained earnings

10,328Β 

15,695Β 

24,788Β 

30,155Β 

Consolidated Cash Flow Statement

year ended 30th June 2008

2008

2007

Β£000

Β£000

Operating activities

Cash (used in)/from operations

(4,148)

4,482Β 

Interest received/(paid)

187Β 

(602)

Income tax received/(paid)

5Β 

(635)

(3,956)

3,245Β 

Investing activities

Purchase of property, plant and equipment

(2,323)

(2,574)

Proceeds on disposal of property, plant and equipment

16,261Β 

658Β 

Disposal of subsidiary undertaking

2,409Β 

-

16,347Β 

(1,916)

Financing activities

Β 

Equity dividends paid

(1,110)

(1,110)

Redemption of loan notes

(88)

(80)

New bank loans received

-

3,000Β 

Repayment of bank loans

(3,652)

(2,914)

(4,850)

(1,104)

Net increase in cash and cash equivalents

7,541Β 

225Β 

Cash and cash equivalents at start of the year

(1,478)

(1,703)

Cash and cash equivalents at end of the year

6,063Β 

(1,478)

Statement of Recognised Income and Expense

year ended 30th June 2008

2008

Β 2007Β 

Β£000

Β£000

Β£000

Β£000

(Loss)/profit attributable to shareholders of the group

(3,613)

3,096Β 

Actuarial (losses)/gains recognised in the pension scheme

(920)

3,620Β 

Related deferred taxation

276Β 

(1,086)

(644)

2,534Β 

Total recognised income and expense relating to the year

(4,257)

5,630Β 

Notes:

In accordance with Rule 20 of the AIM Rules,Β AireaΒ confirms that the annualΒ report and accountsΒ for the year ended 30thΒ June 2008Β will be posted toΒ shareholders and will be available to view on the Company's website atΒ www.aireaplc.co.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FR FKAKKABKDPCB
Date   Source Headline
16th Jun 20269:49 amRNSDirector / PDMR Dealing
8th Jun 20265:10 pmRNSExercise of Options / PDMR notification
6th May 20263:06 pmRNSResult of AGM
6th May 20262:00 pmRNSAGM Statement
20th Apr 202612:23 pmRNSDirector/PDMR Dealing
26th Mar 20267:00 amRNSFinal Results for the year ended 31 December 2025
9th Mar 20267:00 amRNSNotice of Results
11th Feb 20268:52 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNSPre-close Trading Update
1st Oct 20259:08 amRNSHolding(s) in Company
30th Sep 20254:12 pmRNSDivestment of Investment Property
30th Sep 20257:00 amRNSInterim Results
29th Jul 20257:00 amRNSPre-close Trading Update and Notice of Results
7th May 20253:06 pmRNSResult of AGM
7th May 202512:01 pmRNSDirector/PDMR Dealing
7th May 202512:00 pmRNSAGM Statement
28th Mar 20257:00 amRNSDirector/PDMR Dealings
27th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
10th Mar 20257:00 amRNSNotice of Results
30th Jan 20257:00 amRNS-ROpening of Dubai Showroom
23rd Jan 202510:40 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSPre-close Trading Update
26th Sep 202411:43 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSInterim Results
6th Aug 20247:00 amRNSPre-close Trading Update and Notice of Results
28th Jun 20247:00 amRNSLong Term Incentive Plan Awards
8th May 20243:07 pmRNSResult of AGM
8th May 202412:00 pmRNSAGM Statement
26th Mar 20247:00 amRNSFinal Results for the year ended 31 December 2023
11th Mar 20247:00 amRNSNotice of Results
24th Jan 20247:00 amRNSTrading update and £5.0m investment in facility
3rd Oct 20237:00 amRNSAppointment of Chief Financial Officer
28th Jul 202310:30 amRNSHolding(s) in Company
27th Jul 20237:00 amRNSInterim Results
4th Jul 20233:00 pmRNSDirectorate Change
22nd Jun 20237:00 amRNSHolding(s) in Company
10th May 20232:56 pmRNSResult of AGM
10th May 202312:00 pmRNSAGM Statement
10th May 20237:00 amRNSAppointment of Independent Non-Executive Director
13th Apr 20233:42 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSFinal Results for the year ended 31 December 2022
16th Dec 20227:00 amRNSLong Term Incentive Plan Awards
7th Dec 20224:59 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSAppointment of Chief Executive
29th Jul 20221:54 pmRNSHolding(s) in Company
28th Jul 20227:00 amRNSInterim Report
24th May 20223:02 pmRNSRe Dividend
17th May 20224:01 pmRNSResult of AGM
12th Apr 20227:00 amRNSFinal Results for the year ended 31 December 2021
29th Mar 20224:40 pmRNSDeath of a Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.